Literature DB >> 2480898

Bleomycin-kanamycin resistance as a marker of the presence of transposon Tn5 in clinical strains of Escherichia coli.

F Baquero1, M A Saldaña, J Blazquez, R G Palacios, J M Aguiar, J L Martinez, M F Vicente, C Rubio, R Gómez-Lus.   

Abstract

The aminoglycoside modifying enzyme aminoglycoside 3'-phosphotransferase II (APH(3')II) is encoded for on transposon Tn5 by the aphA gene, in the same operon as the ble gene determining bleomycin resistance. To document this linkage 82 kanamycin-resistant Escherichia coli strains of clinical origin were studied; all 18 isolates presenting bleomycin-kanamycin resistance were shown by an enzymatic assay to produce APH(3')II, and the presence of Tn5 was demonstrated by gene hybridization. Similarly, bleomycin-kanamycin resistance was shown to be linked to APH(3')II production in Salmonella spp. The epidemiology of strains with Tn5-encoded APH(3')II may thus be studied, at least in Escherichia coli, by a simple diffusion test using bleomycin and kanamycin discs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2480898     DOI: 10.1007/bf01967573

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance.

Authors:  R A Jorgensen; S J Rothstein; W S Reznikoff
Journal:  Mol Gen Genet       Date:  1979

2.  Expression of Tn5-encoded streptomycin resistance in E. coli.

Authors:  P Mazodier; O Genilloud; E Giraud; F Gasser
Journal:  Mol Gen Genet       Date:  1986-09

3.  High-level amikacin resistance in Escherichia coli due to phosphorylation and impaired aminoglycoside uptake.

Authors:  M H Perlin; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

4.  Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coli.

Authors:  G P Bongaerts; G M Kaptijn
Journal:  Antimicrob Agents Chemother       Date:  1981-09       Impact factor: 5.191

5.  The transposon Tn5 carries a bleomycin-resistance determinant.

Authors:  O Genilloud; M C Garrido; F Moreno
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

6.  Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.

Authors:  M H Perlin; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191

7.  Amikacin resistance associated with a plasmid-borne aminoglycoside phosphotransferase in Escherichia coli.

Authors:  M H Perlin; S A Lerner
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

8.  Bleomycin resistance conferred by a drug-binding protein.

Authors:  A Gatignol; H Durand; G Tiraby
Journal:  FEBS Lett       Date:  1988-03-28       Impact factor: 4.124

9.  Transposition of R factor genes to bacteriophage lambda.

Authors:  D E Berg; J Davies; B Allet; J D Rochaix
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

10.  Plasmid-determined bleomycin resistance in Staphylococcus aureus.

Authors:  D Semon; N R Movva; T F Smith; M el Alama; J Davies
Journal:  Plasmid       Date:  1987-01       Impact factor: 3.466

View more
  3 in total

1.  Genetic analysis of the Mycobacterium smegmatis rpsL promoter.

Authors:  T J Kenney; G Churchward
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

2.  Activation of the cryptic aac(6')-Iy aminoglycoside resistance gene of Salmonella by a chromosomal deletion generating a transcriptional fusion.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  J Bacteriol       Date:  1999-11       Impact factor: 3.490

3.  Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.

Authors:  A Fernandez-Rodriguez; R Canton; J C Perez-Diaz; J Martinez-Beltran; J J Picazo; F Baquero
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.